Categories: News

Hologic to Webcast Presentation at the 40th Annual J.P. Morgan Healthcare Conference

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

MARLBOROUGH, Mass.–(BUSINESS WIRE)–#HOLX–Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022 at 1:30 p.m. Eastern Time.

The presentation and Q&A session will be webcast live and may be accessed through a link on the investors section of Hologic’s website at http://investors.hologic.com. The webcast will be available for 30 days following the event.

About Hologic, Inc.

Hologic, Inc. is an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com.

SOURCE: Hologic, Inc.

Contacts

Paula Izidoro

Senior Investor Relations Specialist

(858) 410-8904

paula.izidoro@hologic.com

Staff

Recent Posts

MOEA Takes Home 7 Awards at R&D100

18 Years, 100+ Awards: Taiwan's R&D Prowess Shines on Global StageTAIPEI, Nov. 21, 2025 /PRNewswire/…

21 minutes ago

IEI Secures TFDA QMS Approval and ISO 13485 Certification, Reinforcing Audit-Ready Manufacturing for MedTech Design Transfers

Dual certifications streamline global design transfers and regulatory compliance.TAIPEI, Nov. 21, 2025 /PRNewswire/ -- IEI…

21 minutes ago

Kanazawa University research: Scientists develop a new method to measure cellular energy in real time

KANAZAWA, Japan, Nov. 20, 2025 /PRNewswire/ -- Researchers at the Nano Life Science Institute (WPI-NanoLSI),…

6 hours ago

Oracle Names Stephen Rusckowski to the Board of Directors

AUSTIN, Texas, Nov. 20, 2025 /PRNewswire/ -- Oracle Corporation (NYSE: ORCL) today announced that it…

6 hours ago

Onco-Innovations Advances Optimization and Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services to Support Future Phase 1 Clinical Studies

VANCOUVER, BC / ACCESS Newswire / November 20, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN:A3EKSZ)…

9 hours ago

GE HealthCare to acquire Intelerad, advancing cloud-enabled enterprise imaging across care settings

Creates a fully-connected, cloud-first imaging ecosystem spanning high-growth outpatient and ambulatory, teleradiology and hospital settings…

12 hours ago